EPSILON HEALTHCARE Valuation

9TH0 Stock  EUR 0.01  0.00  0.00%   
EPSILON HEALTHCARE seems to be overvalued based on Macroaxis valuation methodology. Our model computes the value of EPSILON HEALTHCARE LTD from evaluating the firm fundamentals such as Profit Margin of (2.41) %, return on asset of -0.14, and Shares Outstanding of 300.35 M as well as inspecting its technical indicators and probability of bankruptcy.
Overvalued
Today
0.01
Please note that EPSILON HEALTHCARE's price fluctuation is very steady at this time. Calculation of the real value of EPSILON HEALTHCARE LTD is based on 3 months time horizon. Increasing EPSILON HEALTHCARE's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the EPSILON stock is determined by what a typical buyer is willing to pay for full or partial control of EPSILON HEALTHCARE LTD. Since EPSILON HEALTHCARE is currently traded on the exchange, buyers and sellers on that exchange determine the market value of EPSILON Stock. However, EPSILON HEALTHCARE's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.0075 Real  0.0063 Hype  0.0075 Naive  0.0075
The real value of EPSILON Stock, also known as its intrinsic value, is the underlying worth of EPSILON HEALTHCARE LTD Company, which is reflected in its stock price. It is based on EPSILON HEALTHCARE's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of EPSILON HEALTHCARE's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.01
Real Value
0.01
Upside
Estimating the potential upside or downside of EPSILON HEALTHCARE LTD helps investors to forecast how EPSILON stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of EPSILON HEALTHCARE more accurately as focusing exclusively on EPSILON HEALTHCARE's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.010.01
Details
Hype
Prediction
LowEstimatedHigh
0.010.010.01
Details
Naive
Forecast
LowNext ValueHigh
0.010.010.01
Details

EPSILON HEALTHCARE Total Value Analysis

EPSILON HEALTHCARE LTD is presently forecasted to have takeover price of 0 with market capitalization of 4.83 M, debt of 5.11 M, and cash on hands of 6.97 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the EPSILON HEALTHCARE fundamentals before making investing decisions based on enterprise value of the company

EPSILON HEALTHCARE Investor Information

About 28.0% of the company shares are owned by insiders or employees . The company recorded a loss per share of 0.03. EPSILON HEALTHCARE LTD had not issued any dividends in recent years. Based on the measurements of operating efficiency obtained from EPSILON HEALTHCARE's historical financial statements, EPSILON HEALTHCARE LTD is not in a good financial situation at the moment. It has a very high risk of going through financial straits in March.

EPSILON HEALTHCARE Asset Utilization

One of the ways to look at asset utilization of EPSILON is to check how much profit was generated for every dollar of assets it reports. EPSILON HEALTHCARE LTD shows a negative utilization of assets of -0.14 percent, losing €0.001446 for each euro of assets held by the firm. Ineffective asset utilization denotes the company is being less competent with each euro of assets it shows. Put another way, asset utilization of EPSILON HEALTHCARE LTD shows how unsuccessful it operates for each euro spent on its assets.

EPSILON HEALTHCARE Ownership Allocation

EPSILON HEALTHCARE holds a total of 300.35 Million outstanding shares. EPSILON HEALTHCARE LTD retains noticeable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

EPSILON HEALTHCARE Profitability Analysis

The company reported the revenue of 5.46 M. Net Loss for the year was (10.54 M) with profit before overhead, payroll, taxes, and interest of 1.92 M.
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates EPSILON HEALTHCARE's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in EPSILON HEALTHCARE and how it compares across the competition.

About EPSILON HEALTHCARE Valuation

The stock valuation mechanism determines EPSILON HEALTHCARE's current worth on a weekly basis. Our valuation model uses a comparative analysis of EPSILON HEALTHCARE. We calculate exposure to EPSILON HEALTHCARE's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of EPSILON HEALTHCARE's related companies.
Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. EPSILON HEALTHCARE operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.

8 Steps to conduct EPSILON HEALTHCARE's Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates EPSILON HEALTHCARE's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct EPSILON HEALTHCARE's valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain EPSILON HEALTHCARE's financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine EPSILON HEALTHCARE's revenue streams: Identify EPSILON HEALTHCARE's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research EPSILON HEALTHCARE's industry and market trends, including the size of the market, growth rate, and competition.
  • Establish EPSILON HEALTHCARE's growth potential: Evaluate EPSILON HEALTHCARE's management, business model, and growth potential.
  • Determine EPSILON HEALTHCARE's financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate EPSILON HEALTHCARE's estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Complementary Tools for EPSILON Stock analysis

When running EPSILON HEALTHCARE's price analysis, check to measure EPSILON HEALTHCARE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EPSILON HEALTHCARE is operating at the current time. Most of EPSILON HEALTHCARE's value examination focuses on studying past and present price action to predict the probability of EPSILON HEALTHCARE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EPSILON HEALTHCARE's price. Additionally, you may evaluate how the addition of EPSILON HEALTHCARE to your portfolios can decrease your overall portfolio volatility.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Stocks Directory
Find actively traded stocks across global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
CEOs Directory
Screen CEOs from public companies around the world